glp-1 chemical structure Glucagon-like peptide 1 (7-36)amide | C151H229N41O46 | CID 16132173 GLP-1 receptor agonist 11 |

Full publication of combination-therapy data is awaited, however interim analysis from the phase II COURAGE trial (NCT06299098) found 3.3% reduction in lean mass of obese patients treated with the combination of trevogrumab and semaglutide, compared with 6.5% reduction with semaglutide alone [70]

Some patients may have temporary memory loss after the procedure because of monitored anesthesia care

GLP-1 agonist receptors mimic this naturally occurring hormone

1 Tirzepatide and semaglutide are the most studied medicines for this purpose, with multiple clinical studies showing impressive results

Manufacturers took note, and began to tune them for weight-loss and convenience